國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG)
0.1.0 - trial-use
This page is part of the 國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG) (v0.1.0: Releases) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Active as of 2024-09-01 |
{
"resourceType" : "CodeSystem",
"id" : "CRLF-LVI",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem CRLF-LVI</b></p><a name=\"CRLF-LVI\"> </a><a name=\"hcCRLF-LVI\"> </a><a name=\"CRLF-LVI-en-US\"> </a><p>This case-sensitive code system <code>https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-LVI</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">0<a name=\"CRLF-LVI-0\"> </a></td><td>無淋巴管或血管侵犯</td></tr><tr><td style=\"white-space:nowrap\">1<a name=\"CRLF-LVI-1\"> </a></td><td>有淋巴管或血管侵犯</td></tr><tr><td style=\"white-space:nowrap\">7<a name=\"CRLF-LVI-7\"> </a></td><td>(1)病理報告描述為 NA 或無法評估 (2)病理樣本非常小,無法判斷 (3)病理報告提及樣本不足以判斷是否有淋巴管或血管侵犯 (4)所有原發部位病理報告皆未描述淋巴管或血管侵犯情形 (5)原發部位有執行病理檢查,但病理報告描述無惡性細胞</td></tr><tr><td style=\"white-space:nowrap\">8<a name=\"CRLF-LVI-8\"> </a></td><td>不適用。(1)GIST、NETs、High grade dysplasia (severe dysplasia)、原位癌 (2)淋巴瘤及白血病 (3)Plasma cell myeloma (4)中樞神經系統之惡性腫瘤 (5)原發部位不詳個案 (6)原發部位未執行病理檢查或僅細胞學檢查</td></tr><tr><td style=\"white-space:nowrap\">9<a name=\"CRLF-LVI-9\"> </a></td><td>病歷未記載或不詳</td></tr></table></div>"
},
"url" : "https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-LVI",
"version" : "0.1.0",
"name" : "CRLFLVICodeSystem",
"title" : "淋巴管或血管侵犯代碼系統",
"status" : "active",
"experimental" : false,
"date" : "2024-09-01",
"publisher" : "國家級人體生物資料庫整合平台",
"contact" : [
{
"telecom" : [
{
"system" : "url",
"value" : "https://ghd.tw/"
}
]
}
],
"description" : "CRLF淋巴管或血管侵犯代碼系統",
"caseSensitive" : true,
"content" : "complete",
"count" : 5,
"concept" : [
{
"code" : "0",
"display" : "無淋巴管或血管侵犯"
},
{
"code" : "1",
"display" : "有淋巴管或血管侵犯"
},
{
"code" : "7",
"display" : "(1)病理報告描述為 NA 或無法評估 (2)病理樣本非常小,無法判斷 (3)病理報告提及樣本不足以判斷是否有淋巴管或血管侵犯 (4)所有原發部位病理報告皆未描述淋巴管或血管侵犯情形 (5)原發部位有執行病理檢查,但病理報告描述無惡性細胞"
},
{
"code" : "8",
"display" : "不適用。(1)GIST、NETs、High grade dysplasia (severe dysplasia)、原位癌 (2)淋巴瘤及白血病 (3)Plasma cell myeloma (4)中樞神經系統之惡性腫瘤 (5)原發部位不詳個案 (6)原發部位未執行病理檢查或僅細胞學檢查"
},
{
"code" : "9",
"display" : "病歷未記載或不詳"
}
]
}